Unknown

Dataset Information

Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial.


ABSTRACT:

Objectives

To assess the effect of anticoagulation with bivalirudin administered intravenously on gas-exchange in patients with COVID-19 and respiratory failure using invasive mechanical ventilation.

Trial design

This is a single centre parallel group, superiority, randomized (1:1 allocation ratio) controlled trial.

Participants

All patients admitted to the Hamad Medical Corporation -ICU in Qatar for COVID-19 associated respiratory distress and in need of mechanical ventilation are screened for eligibility.

Inclusion criteria

all adult patients admitted to the ICU who test positive for COVID-19 by PCR-test and in need for mechanical ventilation are eligible for inclusion. Upon crossing the limit of D-dimers (1.2 mg/L) these patients are routinely treated with a

SUBMITTER: Kharma N 

PROVIDER: S-EPMC7476433 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature